Ross H E
Comorbidity and Behavioural Risk Factors Unit, Addiction Research Foundation, Toronto, Canada.
Addiction. 1993 Feb;88(2):209-18. doi: 10.1111/j.1360-0443.1993.tb00804.x.
The prevalence and correlates of benzodiazepine use and anxiolytic abuse and dependence are examined in a sample of 427 patients in Toronto, Canada, who met lifetime DSM-III criteria for alcohol abuse or dependence. The patients were evaluated with the NIMH-DIS and other standard psychiatric and substance abuse rating scales. Forty per cent were recent users of benzodiazepines and 20% had abused or been dependent upon anxiolytics, including benzodiazepines, during their lifetime. Patients with antisocial personality disorder (ASPD) were at higher risk for an anxiolytic disorder as were women and the unemployed. Recent users of benzodiazepines showed more current psychological distress, depressive symptomatology and more severe substance abuse problems than other patients and were more likely to have a lifetime DSM-III anxiety disorder. Patients with anxiolytic disorders, even if ASPD was controlled for, showed more psychiatric impairment and drug abuse problems than the remaining patients. Of those with a positive urine screen, 46% did not report using benzodiazepines in the previous week. Nineteen per cent of the patients who did not report benzodiazepine use in the previous week had a positive urine screen and were more likely to be found in the detoxification unit.
在加拿大多伦多的427名符合酒精滥用或依赖终身DSM-III标准的患者样本中,研究了苯二氮䓬类药物使用、抗焦虑药滥用及依赖的患病率及其相关因素。患者接受了美国国立精神卫生研究所诊断访谈表(NIMH-DIS)及其他标准的精神科和药物滥用评定量表评估。40%为苯二氮䓬类药物近期使用者,20%在其一生中曾滥用或依赖包括苯二氮䓬类药物在内的抗焦虑药。反社会人格障碍(ASPD)患者、女性及失业者患抗焦虑药障碍的风险更高。苯二氮䓬类药物近期使用者比其他患者表现出更多当前心理困扰、抑郁症状及更严重的药物滥用问题,且更有可能患终身DSM-III焦虑症。即使控制了ASPD,抗焦虑药障碍患者仍比其余患者表现出更多精神障碍及药物滥用问题。在尿筛查呈阳性者中,46%在前一周未报告使用苯二氮䓬类药物。在前一周未报告使用苯二氮䓬类药物的患者中,19%尿筛查呈阳性,且更有可能在戒毒所被发现。